SOBI, INC
WALTHAM, DE

Swedish Orphan Biovitrum AB (publ), commonly known as Sobi, is an established international biopharmaceutical company headquartered in Stockholm, Sweden. As a public limited liability company listed on Nasdaq Stockholm, Sobi focuses on providing innovative treatments for rare diseases while maintaining robust business operations across 25 countries and delivering treatments globally to over 60 countries. Sobi primarily operates within two key sectors: Haemophilia and Specialty Care. In the arena of haemophilia, it aims to lead in Europe, the Middle East, and Africa. Meanwhile, its Specialty Care division targets a variety of rare diseases and specialty indications leveraging Sobi's expertise and experience in niche markets. The company’s research and development efforts are directed toward key areas such as haemophilia, inflammation, genetic, and metabolic disorders. Fostering an integrated biotechnology approach allows Sobi to manage its value chain efficiently from research through manufacturing to patient access and distribution. This holistic strategy supports its capacity for early-stage drug development collaborations and the delivery of proprietary drugs. Sobis' corporate governance is governed by the Swedish Corporate Governance Code, and it upholds a 'comply or explain' principle relating to these standards. The company holds its Annual General Meeting typically in the first half of the year to discuss key decisions like board elections, auditor appointments, director remuneration, and strategies for business development. As per recent filings, Sobi's incorporation status is recorded under Florida state jurisdiction with specific details including a registered office at 890 Winter Street, Suite 115, Waltham, MA. The company retains its primary operations in Sweden while being noted for its substantial reach and influence across multiple global territories. Sobi's Board comprises distinguished members such as Cameron McDonough (Director), Rami Levin (President), and Nils Fredrik Berg (Secretary). They guide the organization towards achieving its strategic objectives in advancing healthcare solutions for underserved patients worldwide. The company maintains an online presence through its website available at sobi.com.